CXCL10 and neoplasm: Beyond direct tumor clearance, CAR-Ms secreted T cell-recruiting chemokines (e.g., Cxcl10), facilitated antigen presentation to amplify T cell priming, and reprogrammed immunosuppressive myeloid populations toward an immunostimulatory M1 phenotype.